KKR Deal Bolsters JB Chemicals’ Expansion Efforts

Open Offer At 4% Premium To Current Price

US private equity firm KKR is to acquire a majority stake in JB Chemicals, accelerating the Indian group's growth plans in branded formulations. Post a 54% stake acquisition for $414m via part-purchase from the founders and an open offer at INR745 per share, KKR's final stake could rise to 64.9% if founders offer more shares.

Hand reaches out to touch 'ACQUISITION' touch-screen button
KKR Expands Healthcare Portfolio With JB Chemicals Acquisition • Source: Shutterstock

More from Deals

More from Business